Monthly Archives: April 2009

Mexican Flu Outbreak 2009: SPECIAL REPORT

This unprecedented H1N1-H5N1 flu outbreak implicates the Ango-American Vaccine Pipeline, says world leading consumer health protector, Dr. Leonard Horowitz

Consider the skyrocketing stock values of Novavax, Inc., precipitated by dozens of alleged flu deaths in Mexico. Then investigate the leading Anglo-American network of genetic engineers manipulating, mutating, and distributing these viruses. The evidence compels you, for the benefit of public health and safety to seriously consider, even decree, a conspiracy to commit genocide, according to this Harvard trained expert in emerging diseases.

Here, Dr. Horowitz urges an investigation of Dr. James S. Robertson, Englands leading bioengineer of flu viruses for the vaccine industry, and avid promoter of U.S. Government funding for lucrative biodefense contracts, along with collaborators at the US Centers for Disease Control & Prevention (CDC). These suspects helped Novavax, Inc., in Bethesda, Maryland, produce genetically-modified recombinants of the avian, swine, and Spanish flu viruses, H5N1 and H1N1, nearly identical to the unprecedented Mexican virus that is allegedly spreading to the United States at the time of this posting. The outbreak was precisely timed to promote the companys new research and huge vaccine stockpiling contracts.

Scientists at the U.S. Centers for Disease Control (CDC) are implicated through collaborations and publications involving private contracts with Novavax, a company that obtains its biosimulars through CDC Influenza Branch director, Ruben O. Donis, and Dr. Rick Bright, previously working with Donis at the CDC, now Novavaxs Vice President of Global Influenza Programs.

Descriptions of this virus is pathognomonic, or diagnostic, of a virus that came from Robertsons circle of friends, Dr. Horowitz charges. No other group in the world takes H5N1 Asian flu infected chickens, brings them to Europe, extracts their DNA, combines their proteins with H1N1 viruses from the 1918 Spanish flu isolate, additionally mixes in swine flu genes from pigs, then reverse engineers them to infect humans. The end product could only have ended up in Mexico via the United States from Britain in care of the CDC. The CDC had to have sent them to Novavax, where Rick Brights team is now implicated in a conspiracy to commit genocide—the mass killing of people for profit.

Advertisements

Leave a comment

Filed under Health/Food Related

New Flu Outbreak Implicates Anglo-American “Vaccine Pipeline”

Tetrahedron Publishing Group
Health Science Communications
for People Around the World
217 Cedar St., Suite #326
Sandpoint, ID 83864
208-265-8065
NEWS RELEASE
Release: No. H1N1-15=6
Date Mailed: April 25, 2009
For Immediate Release
Contact: Jackie Lindenbach-208/265-8065; 800/336-9266
H1N1-H5N1 Flu Outbreak Implicates Anglo-American
“Vaccine Pipeline” Says Expert Dr. Leonard Horowitz

Los Angeles, CA- Skyrocketing stock values of Novavax, Inc.,1 precipitated by dozens of flu deaths in Mex­ico, implicates a leading Anglo- American network of genetic engineers in a conspiracy to commit genocide, according to a Harvard trained expert in emerging diseases, Dr. Leonard Horowitz.
Dr. James S. Robertson, England’s leading bioengineer of flu viruses for the vaccine industry, and avid promoter of U.S. Government funding for lucrative “biodefense” contracts, along with collaborators at the US Centers for Disease Control & Prevention (CDC), helped Novavax, Inc., in Bethesda, Maryland, produce genetically-modi­fied recombinants of the avian, swine, and Spanish flu viruses, H5N1 and H1N1, nearly identical to the unprec­edented Mexican virus that has now spread to the United States. The outbreak was precisely timed to promote the company’s new research and huge vaccine stockpiling contracts, according to Dr. Horowitz.2

Scientists at the U.S. Centers for Disease Control (CDC) are implicated through collaborations and publica­ tions involving private contracts with Novavax, a company that obtains its “biosimulars” through CDC Influ­enza Branch director, Ruben O. Donis, and Dr. Rick Bright, previously working with Donis at the CDC, now Novavax’s Vice President of Global Influenza Programs.

Evidence for the conspiracy to commit deadly duplicity in the vaccine industry includes the genetic markers on the novel flu virus now spreading from Mexico to America. The virus is “genetically different from the fully human H1N1 seasonal influenza virus that has been circulating globally for the past few years,” according to Reuters and government officials. “The new flu virus contains DNA typical to avian, swine and human viruses, including elements from European and Asian swine viruses.”3

“That is a description that is pathognomonic, or diagnostic, of a virus that came from Robertson’s circle of friends,” Dr. Horowitz claims. “No other group in the world takes H5N1 Asian flu infected chickens, brings them to Europe, extracts their DNA, combines their proteins with H1N1 viruses from the 1918 Spanish flu iso­late, additionally mixes in swine flu genes from pigs, then ‘reverse engineers’ them to infect humans. The end product that Reuter’s describes could only end up in Mexico via the United States from Britain in care of the CDC. Ruben Donis at the CDC had to have sent them to Novavax, where Rick Bright’s team is now implicated in a conspiracy to commit genocide-the mass killing of people for profit.”

Novavax’s preliminary report in the Journal of Virology, with co-authors from the CDC in Atlanta, was posted online at the precise time Mexican officials began reporting deaths from this new strain of flu that is clearly an unprecedented recombinant of at least three H5N1 and H1N1 strains. Novavax’s Johnny-on-the-spot vaccine was prepared under the CDC’s “fast track” approval process speciously using these three strains never known to infect any human in Mexico.

Therefore, the statistical probability this virus came from this company of “experts” is extremely high. Alter­ natively, anticipated arguments the virus arrived in Mexico by serendipity, at this precise time in Novavax’s history, is ridiculously remote. “These doctor’s conflicting corporate, scientific, and financial interests evidence criminal malfeasance,” said Dr. Leonard Horowitz, an internationally known humanitarian, award winning consumer health activist, and author of sixteen books including, Emerging Viruses: AIDS & Ebola-Nature, Accident or Intentional? (1998, Tetra­hedron.org; 1-888-508-4787), His book, and associated scientific publications, have been cited by numerous authorities as providing compelling evidence the AIDS virus came from a lab.

“The most chilling evidence against the Robertson-Novavax (RN) vaccine pipeline, besides Robertson being the “gatekeeper” for multi- billion dollar vaccine stockpiling deals, is Robertson’s influence over the European Medicines Agency (EMEA)-a quasi-corporate quasi- scientific think tank serving the European [Economic] Union and drug industry’s special interests,” Dr. Horowitz said.

Dr. Robertson is the Principal Scientist in the Division of Virology at the National Institute for Biological Standards and Control (NIBSC), akin to the USFDA in the UK. During a meeting in April, 2006, discussing the standardization of influenza vaccines on behalf of the World Health Organization (WHO), it was disclosed, “the NIBSC is involved in the serological testing of vaccine trials; the preparation and distribution of influenza viruses to vaccine manufacturers; and the coordination of EU strain selection[s].” Participants disclosed the EMEA persuades vaccine makers to bank on pandemics, and “invest in pandemic vaccines with the introduction of mock up files,” which is their unassuming way of describing new laboratory engineered influenza viruses also referred to as “biosimilars.” 4

The EMEA waves regulatory fees as an additional incentive to attract more business for allegedly “biodefense.”4

Dr. Robertson, the holder of intellectual property (IP) rights to the genetic technology used to produce the H5N1 and H1N1 “mock up files” used to develop Novavax’s vaccine, waived his ownership of the technology dur­ing the company’s research phase with a guaranteed payoff “when the vaccine is commercialized.” Robertson’s “Material Trade Agreement” (MTA), covering the transfer of these “biosimilars” to Novavax, is expected to return millions of dollars when the vaccine is sold to governments worldwide. 4

Novavax’s commercialization and promotions of their vaccine is largely based on media hype fanning fears and markets for their avian flu, Spanish flu, and swine flu concoctions. Never before this outbreak has such a virus, combining the three most feared flu strains, been identified.

Mexico’s killer, therefore, evidences a laboratory creation sourcing from either Novavax’s lab directly, or their partners at the CDC and NIBSC who maintain multi-million-dollar incentives. The company’s synchronously timed professional publications, mass media releases, product representations and commercialization, evidence financial motives to commit duplicity and mass murder.

Days ago, officials at the CDC expressed serious concerns about this novel flu strain causing a deadly pandem­ic, not disclosing their obvious knowledge that the outbreak must have sourced from the materials used in their cooperative studies with Novavax.5 2

“These doctor’s conflicting corporate, scientific, and financial interests evidence criminal malfeasance. Killing dozens of people for publicity and duplicity in public health; to increase marketability of their new vaccine, is best described as serial homicide to advance genocide-the mass killing of people for profit,” Dr. Leonard Horowitz explained.

The most chilling evidence against Dr. Robertson’s EU research team, besides him being the gatekeeper and chief promoter for multi-billion dollar flu vaccine stockpiling deals, and besides his collaborators being caught red handed here by hard science and common sense, is his stated position that he believes it is wise to “prime” populations worldwide by releasing viruses he and his colleagues are creating. This warning comes from a April 27, 2006, scientific discourse in which Dr. Robertson, and members of his WHO working group, recommended his “biosimilars” be “used to prime the population in advance of the pandemic reaching the UK.”

In other words, the doctors that hold infectious disease responsibility for the world have already decided to loose their viruses on unwitting populations in advance of threatened outbreaks.

 

-End-Note to Journalists: For interviews with Dr. James Robertson, the NIBSC lists his contact as: NIBSC, Blanche Lane, South Mimms Potters Bar, Herts EN6 3QG; Tel: +44 1707 641304; Fax: +44 1707 641050. Dr. Horowitz can be reached for interviews in southern California, at 949-715-2337. Ruben O. Donis;s contact information at the Influenza Branch, DVRD, NCID, Centers for Disease Control and Prevention, is: Mailstop G16, 1600 Clif­ton Rd, Atlanta, GA 30333, USA; fax: 404-639-2334; email: rdonis@ cdc.gov. Dr. Rick Bright can be reached through Novavax.

REFERENCES:

(1) http://uk.reuters.com/article/governmentFilingsNews/idUKN2445216420090424

(2) http://ukpmc.ac.uk/articlerender.cgi?artid=1242433

(3) Reuters news release. FACTBOX-New flu strain is a genetic mix. April, 24, 2009. http://www.alertnet.org/thenews/newsdesk/N23371192.htm

(4) (http://74.125.95.132/search?q=cache:SPJ1B5-EK3sJ:royalsociety.org/downloaddoc.asp%3Fid%3D3521+Summary+of+Oral+Evidence+Dr.+John+Wood&cd=1&hl=en&ct=clnk&gl=us&client=firefox-a)

(5) “CDC Press Briefing Transcripts April 24, 2009”. Cdc.gov. 2009-04-24. http://www.cdc.gov/media/tran­scripts/2009/t090424.htm. Retrieved on 2009-04-25.

(6) Note: The long term risks of governments purchasing, and people accepting, vaccines for the flu are un­studied. Yet, the industry and corporate-controlled governments declare war on biology and discourage “green” alternatives to vaccinations, such as the most advanced silver hydrosols (e.g., Oxysilver) in which nano-size anti-microbial silver is bonded to the oxygen in Water (See: http://www.Oxysilver.com). There would be no need for polluting people’s bodies, and the environment, with heavy metals such as mercury and aluminum, or suffering side effects from antibiotics, if public health officials promoted the new powerfully protective and curative silver hydrosols.
3

 

 

 

 

 

1 Comment

Filed under Conspiracy/Coincidence, Health/Food Related

FDA Complicit in Pushing Pharmaceutical Drugs

 

 

Source:
NewStandard, April 20, 2007
Title: “FDA Complicit in Pushing Prescription Drugs, Ad Critics Say”
Author: Shreema Mehta

Student Researchers: Lauren Anderson, Corey Sharp-Sabatino, and Marie Daghlian

Faculty Evaluator: Noel Byrne, PhD

While the US Food and Drug Administration (FDA) turns a blind eye, drug companies are making false, unsubstantiated, and misleading claims in their advertising, often withholding mandated disclosure of dangerous side effects. Though companies are required to submit their advertisements to the FDA, the agency does not review them before they are released to the public. A Government Accountability Office report released November 2006 found that the FDA reviews only a small portion of the advertisements it receives, and does not review them using consistent criteria.

Claiming lack of funds and resources necessary to impose effective regulations on drug marketing, the FDA is asking Congress to charge drug companies fees in order to fund FDA review of advertisements before they go public as part of renewing the Prescription Drug User Fee Act (PDUFA). PDUFA has come under fire from consumer advocates who say it gives the pharmaceutical industry too much leverage over the FDA and has resulted in rushing drugs to market. But the FDA hopes that if Congress approves the plan, it will raise more than $6 million annually through “user fees” to review advertisements.

Although Congress may approve the plan, author Shreema Mehta says a range of public-interest groups, from ad critics at Commercial Alert to senior advocates at Gray Panthers, want an outright ban on all prescription drug advertisements. Public Citizen and Consumers Union warn that the FDA review of drug advertisements will likewise be tainted if funded by the very companies the FDA is charged with scrutinizing. Critics are calling for stricter regulations over drug companies and they say eliminating the financial ties between the FDA and the pharmaceutical industry should be the first step.

But the pharmaceutical industry is not the only industry that benefits from inconsistent FDA reviews and inadequate investigations of advertising claims. One of the nation’s biggest infant bottled water companies, Nursery Water, is misleading parents with erroneous information and false health claims on its website and in advertising materials, touting the safety and benefits of fluoride in infant bottled water, in clear violation of Federal Trade Commission (FTC) and FDA rules.

A letter sent from scientists at the Environmental Working Group (EWG) to officials at the FDA and FTC uncovers EWG’s extensive review of Nursery Water’s claims that both misrepresent the position of the American Academy of Pediatrics, which states, “supplementary fluoride should not be provided during the first six months of life” (AAP 2005), and contradict the official position of the FDA, which states, “the health claim [for fluoride] is not intended for use on bottled water products specifically marketed for use by infants” (FDA 2006).1

Mehta reports that representatives from the food and pharmaceutical industries say banning ads would violate the First Amendment. “In our system of jurisprudence we have a very high threshold that protects the right to free speech, whether it’s political or commercial,” Jim Davidson, attorney for the drug-company-funded Advertising Coalition, told the Associated Press.

Mehta warns of the increased leverage food and drug companies may have over the FDA should Congress approve the fee plan. She reports that in 2005, pharmaceutical companies spent about $4.2 billion in advertisements aimed at the public, known as “direct-to-consumer” ads, up from about $2.5 billion in 2000 and $1.1 billion in 1997. And the promoting of drugs to physicians, with almost $7.2 billion spent in 2005, dwarfs advertising to the public. At the same time, public spending on prescription drugs has steadily increased, reaching about $140 billion in 2001, more than tripling since 1990.

Meanwhile, Mehta reports that it’s not clear whether the FDA reviews most advertisements at all. The agency can direct drug companies to change their advertisements after they are released to the public if it finds they violate regulations, but does no screening before the release of ads that may be dangerously deceptive.

Citation

1. Anila Jacob, M.D., M.P.H. and Jane Houlihan, “EWG calls for Investigation of Nursery Water,” Environmental Working Group, February 1, 2008.

UPDATE BY SHREEMA MEHTA

Americans are taking more prescription drugs than ever before, leading the world in drug consumption and reaping huge profits for pharmaceutical companies. America is also one of the few countries that allow public advertising of prescription drugs. This is not a coincidence. Many doctors and consumer advocates have criticized advertisements featuring beaming people explaining how Valtrex changed their lives as deceptive, inaccurate, and invasive to the doctor-patient relationship. Many activists favor an outright ban on prescription drug ads; others call for strict regulation. This article dealt with the FDA’s ties to the pharmaceutical industry and its proposal to regulate what critics feel is dangerously deceptive advertising by charging drug companies to review their commercials.

A few months after this article ran, President Bush renewed the Prescription Drug User Fee, which includes the industry-funded review process of drug advertisements, putting into effect what critics argue is yet another conflict of interest in the agency.

Though the Washington Post ran several articles on PDUFA, few explored the importance of the new proposal for company-funded advertisement regulation. Though press coverage of the problems of drug advertising is slim, advocacy groups remain active on the issue.

Commercial Alert runs a prescription drug ad campaign that is currently working to raise support for the Public Health Protection Act, which would ban drug ads designed for the public. They are on the web at http://www.commercialalert.org/. The Consumers Union also supports this bill. Learn more about their campaign at https://secure.consumersunion.org/site/Advocacy?JServSessionIdr009=vjqvq0rk51.app44a&cmd=display&page=UserAction&id=1889.

http://www.projectcensored.org/top-stories/articles/23-fda-complicit-in-pushing-pharmaceutical-drugs/

Leave a comment

Filed under Health/Food Related